Kaplan, P.
6969  results:
Search for persons X
?
 
?
2

OC-0307 Results of the ESTRO plan quality assessment 2020 o..:

Kaplan, L.P. ; Placidi, L. ; Bäck, A....
Radiotherapy and Oncology.  161 (2021)  - p. S214-S216 , 2021
 
?
3

PO-1898 Trade-off between microscopic disease and OARs in a..:

Kaplan, L.P. ; Holm, A.I.S. ; Eriksen, J.G....
Radiotherapy and Oncology.  161 (2021)  - p. S1618-S1620 , 2021
 
?
 
?
 
?
6

OC-0520 Inter-observer variations in plan evaluation:

Kaplan, L.P. ; Holm, A.I.S. ; Elstrøm, U.V....
Radiotherapy and Oncology.  133 (2019)  - p. S271-S272 , 2019
 
?
8

Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamu..:

Ghia, P. ; Pluta, A. ; Wach, M....
Hematological Oncology.  37 (2019)  S2 - p. 86-87 , 2019
 
?
 
?
10

EP-2060: Daily dose calculation using CBCT images can trigg..:

Hoffmann, L. ; Khalil, A.A. ; Knap, M.M....
Radiotherapy and Oncology.  127 (2018)  - p. S1129-S1130 , 2018
 
?
 
?
12

OC-0062: Correcting for linear energy transfer dependent qu..:

Høye, E.M. ; Sadel, M. ; Muren, L.P....
Radiotherapy and Oncology.  123 (2017)  - p. S29-S30 , 2017
 
?
13

Omalizumab substantially improves dermatology‐related quali..:

Finlay, A.Y. ; Kaplan, A.P. ; Beck, L.A....
Journal of the European Academy of Dermatology and Venereology.  31 (2017)  10 - p. 1715-1721 , 2017
 
?
14

Why a registry of Chronic Urticaria (CUR) is needed:

Gómez, R.M. ; Jares, E. ; Canonica, G.W....
World Allergy Organization Journal.  10 (2017)  - p. 16 , 2017
 
1-15